Search Results - "Nitiss, Karin C"

Refine Results
  1. 1

    Genome Instability Induced by Topoisomerase Misfunction by Nitiss, Karin C, Bandak, Afif, Berger, James M, Nitiss, John L

    “…Topoisomerases alter DNA topology by making transient DNA strand breaks (DSBs) in DNA. The DNA cleavage reaction mechanism includes the formation of a…”
    Get full text
    Journal Article
  2. 2

    Aberrant topoisomerase-1 DNA lesions are pathogenic in neurodegenerative genome instability syndromes by Katyal, Sachin, Lee, Youngsoo, Nitiss, Karin C, Downing, Susanna M, Li, Yang, Shimada, Mikio, Zhao, Jingfeng, Russell, Helen R, Petrini, John H J, Nitiss, John L, McKinnon, Peter J

    Published in Nature neuroscience (01-06-2014)
    “…In this study, the authors show that topoisomerase-1–DNA cleavage complex (Top1cc) accumulation may be involved in the onset of ataxia telangiectasia and…”
    Get full text
    Journal Article
  3. 3
  4. 4

    TDP1 is required for efficient non-homologous end joining in human cells by Li, Jing, Summerlin, Matthew, Nitiss, Karin C., Nitiss, John L., Hanakahi, Leslyn A.

    Published in DNA repair (01-12-2017)
    “…•Loss of TDP1 significantly reduces end joining of restriction enzyme induced DSBs in human cells.•TDP1-deficeint human cells also show reduced end-joining…”
    Get full text
    Journal Article
  5. 5

    Requirements for MRN endonuclease processing of topoisomerase II-mediated DNA damage in mammalian cells by Sun, Yilun, Soans, Eroica, Mishina, Margarita, Petricci, Elena, Pommier, Yves, Nitiss, Karin C., Nitiss, John L.

    Published in Frontiers in molecular biosciences (23-09-2022)
    “…During a normal topoisomerase II (TOP2) reaction, the enzyme forms a covalent enzyme DNA intermediate consisting of a 5′ phosphotyrosyl linkage between the…”
    Get full text
    Journal Article
  6. 6

    TDP1 promotes assembly of non-homologous end joining protein complexes on DNA by Heo, Jinho, Li, Jing, Summerlin, Matthew, Hays, Annette, Katyal, Sachin, McKinnon, Peter J., Nitiss, Karin C., Nitiss, John L., Hanakahi, Leslyn A.

    Published in DNA repair (01-06-2015)
    “…•End-processing factor TDP1 interacts with the NHEJ factor XLF to form a TDP1:XLF:DNA complex.•XLF stimulates TDP1 enzymatic activity on dsDNA.•TDP1 also…”
    Get full text
    Journal Article
  7. 7

    Tyrosyl-DNA Phosphodiesterase (Tdp1) Participates in the Repair of Top2-Mediated DNA Damage by Nitiss, Karin C., Malik, Mobeen, He, Xiaoping, White, Stephen W., Nitiss, John L.

    “…Agents targeting topoisomerases are active against a wide range of human tumors. Stabilization of covalent complexes, converting topoisomerases into…”
    Get full text
    Journal Article
  8. 8

    Tdp2: a means to fixing the ends by Nitiss, John L, Nitiss, Karin C

    Published in PLoS genetics (01-03-2013)
    “…  A key finding from the original identification of Tdp2 was that the protein was more active in processing 5' phosphotyrosyl-linked oligonucleotides, and that…”
    Get full text
    Journal Article
  9. 9

    Yeast Tdp1 regulates the fidelity of nonhomologous end joining by Bahmed, Karim, Nitiss, Karin C, Nitiss, John L

    “…Tyrosyl-DNA-phosphodiesterase 1 (Tdp1) can disjoin peptides covalently bound to DNA. We assessed the role of Tdp1 in nonhomologous end joining (NHEJ) and found…”
    Get full text
    Journal Article
  10. 10

    Roles of nonhomologous end-joining pathways in surviving topoisomerase II–mediated DNA damage by Malik, Mobeen, Nitiss, Karin C., Enriquez-Rios, Vanessa, Nitiss, John L.

    Published in Molecular cancer therapeutics (01-06-2006)
    “…Topoisomerase II is a target for clinically active anticancer drugs. Drugs targeting these enzymes act by preventing the religation of enzyme-DNA covalent…”
    Get full text
    Journal Article
  11. 11

    Enhancing drug accumulation in Saccharomyces cerevisiae by repression of pleiotropic drug resistance genes with chimeric transcription repressors by Stepanov, Alexander, Nitiss, Karin C, Neale, Geoffrey, Nitiss, John L

    Published in Molecular pharmacology (01-08-2008)
    “…Yeast is a powerful model system for studying the action of small-molecule therapeutics. An important limitation has been low efficacy of many small molecules…”
    Get more information
    Journal Article
  12. 12

    Modeling allosteric mechanisms of eukaryotic type II topoisomerases by Evoli, Stefania, Kariyawasam, Nilusha L, Nitiss, Karin C, Nitiss, John L, Wereszczynski, Jeff

    Published in Biophysical journal (18-06-2024)
    “…Type II topoisomerases (TopoIIs) are ubiquitous enzymes that are involved in crucial nuclear processes such as genome organization, chromosome segregation, and…”
    Get more information
    Journal Article
  13. 13

    Twisting and ironing: doxorubicin cardiotoxicity by mitochondrial DNA damage by Nitiss, Karin C, Nitiss, John L

    Published in Clinical cancer research (15-09-2014)
    “…Anthracyclines are active clinical agents that have multiple mechanisms of cytotoxicity. Cardiotoxicity by anthracyclines limits the therapeutic potential of…”
    Get full text
    Journal Article
  14. 14

    Recurrent mutations in topoisomerase IIα cause a previously undescribed mutator phenotype in human cancers by Boot, Arnoud, Liu, Mo, Stantial, Nicole, Shah, Viraj, Yu, Willie, Nitiss, Karin C, Nitiss, John L, Jinks-Robertson, Sue, Rozen, Steven G

    “…Topoisomerases nick and reseal DNA to relieve torsional stress associated with transcription and replication and to resolve structures such as knots and…”
    Get full text
    Journal Article
  15. 15

    UnTTrapping the ends: A new player in overcoming protein linked DNA damage by Bahmed, Karim, Nitiss, Karin C, Nitiss, John L

    Published in Cell research (01-02-2010)
    “…DNA topoisomerases carry out their reactions by generating transient covalent phosphotyrosine intermediates with DNA [ 1 ]. This reaction mechanism allows…”
    Get full text
    Journal Article
  16. 16

    Using energy to go downhill—a genoprotective role for ATPase activity in DNA topoisomerase II by Bandak, Afif F, Blower, Tim R, Nitiss, Karin C, Shah, Viraj, Nitiss, John L, Berger, James M

    Published in Nucleic acids research (09-02-2024)
    “…Abstract Type II topoisomerases effect topological changes in DNA by cutting a single duplex, passing a second duplex through the break, and resealing the…”
    Get full text
    Journal Article
  17. 17

    A conserved SUMO pathway repairs topoisomerase DNA-protein cross-links by engaging ubiquitin-mediated proteasomal degradation by Sun, Yilun, Miller Jenkins, Lisa M, Su, Yijun P, Nitiss, Karin C, Nitiss, John L, Pommier, Yves

    Published in Science advances (13-11-2020)
    “…Topoisomerases form transient covalent DNA cleavage complexes to perform their reactions. Topoisomerase I cleavage complexes (TOP1ccs) are trapped by…”
    Get full text
    Journal Article
  18. 18

    Naturally mutagenic sequence diversity in a human type II topoisomerase by Bandak, Afif F, Blower, Tim R, Nitiss, Karin C, Gupta, Raveena, Lau, Albert Y, Guha, Ria, Nitiss, John L, Berger, James M

    “…Type II topoisomerases transiently cleave duplex DNA as part of a strand passage mechanism that helps control chromosomal organization and superstructure…”
    Get full text
    Journal Article
  19. 19
  20. 20

    Detection of Topoisomerase Covalent Complexes in Eukaryotic Cells by Anand, Jay, Sun, Yilun, Zhao, Yang, Nitiss, Karin C, Nitiss, John L

    “…DNA topoisomerases carry out topological transformations of DNA by introducing transient DNA breaks. The covalent intermediate of topoisomerase reactions…”
    Get more information
    Journal Article